Balducci, Mario
 Distribuzione geografica
Continente #
EU - Europa 5.109
NA - Nord America 4.709
AS - Asia 2.354
SA - Sud America 549
AF - Africa 72
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 12.812
Nazione #
US - Stati Uniti d'America 4.581
DE - Germania 2.183
SG - Singapore 920
SE - Svezia 816
CN - Cina 790
IT - Italia 494
BR - Brasile 491
UA - Ucraina 378
FR - Francia 328
GB - Regno Unito 224
IE - Irlanda 205
IN - India 204
ID - Indonesia 128
FI - Finlandia 124
CA - Canada 91
RU - Federazione Russa 88
TR - Turchia 60
BE - Belgio 56
VN - Vietnam 56
CZ - Repubblica Ceca 40
BD - Bangladesh 34
JP - Giappone 32
CI - Costa d'Avorio 31
PL - Polonia 29
AT - Austria 26
NL - Olanda 24
CH - Svizzera 22
MX - Messico 17
ZA - Sudafrica 16
EC - Ecuador 15
KR - Corea 15
UZ - Uzbekistan 15
ES - Italia 13
IQ - Iraq 13
AR - Argentina 12
AU - Australia 11
PK - Pakistan 11
VE - Venezuela 11
IR - Iran 10
SA - Arabia Saudita 10
LT - Lituania 9
IL - Israele 8
PE - Perù 8
RO - Romania 8
HK - Hong Kong 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
EU - Europa 6
KE - Kenya 6
KZ - Kazakistan 6
PT - Portogallo 6
BG - Bulgaria 5
KG - Kirghizistan 5
MA - Marocco 5
NO - Norvegia 5
TT - Trinidad e Tobago 5
DZ - Algeria 4
RS - Serbia 4
BO - Bolivia 3
BZ - Belize 3
CL - Cile 3
CO - Colombia 3
DK - Danimarca 3
EE - Estonia 3
EG - Egitto 3
GR - Grecia 3
HN - Honduras 3
JM - Giamaica 3
JO - Giordania 3
PA - Panama 3
TN - Tunisia 3
AM - Armenia 2
HR - Croazia 2
LV - Lettonia 2
MD - Moldavia 2
MY - Malesia 2
OM - Oman 2
PH - Filippine 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AL - Albania 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
IM - Isola di Man 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
NG - Nigeria 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
Totale 12.811
Città #
Chandler 876
Ashburn 410
Singapore 409
Jacksonville 247
Ann Arbor 234
Dublin 203
San Mateo 194
Nanjing 146
Dearborn 136
Nürnberg 132
New York 131
Woodbridge 128
Beijing 126
Jakarta 124
Munich 106
Wilmington 106
Milan 89
Los Angeles 87
Boston 86
Frankfurt am Main 63
Lawrence 63
Marseille 60
Bremen 59
The Dalles 59
Moscow 57
Brussels 56
Nanchang 54
Houston 52
Rome 52
Seattle 50
Zhengzhou 49
Izmir 48
Princeton 46
Redwood City 45
São Paulo 44
Cattolica 43
Hyderabad 43
Chicago 42
Helsinki 41
Redmond 38
Detroit 36
Fairfield 34
Hefei 33
Kunming 32
Toronto 32
Abidjan 31
Leawood 30
Jiaxing 29
Boardman 27
London 26
Shanghai 24
Shenyang 24
Hanoi 22
Mountain View 22
North York 21
Norwalk 21
Düsseldorf 20
University Park 20
Lauterbourg 19
Tianjin 19
Hebei 18
Changsha 17
Nuremberg 17
Ottawa 17
Pune 17
Cambridge 16
Tokyo 16
Vienna 16
Brno 15
Ho Chi Minh City 15
Seoul 15
Auburn Hills 14
Washington 14
Guangzhou 13
Tashkent 13
Zurich 13
Enterprise 12
Hangzhou 12
San Diego 12
San Francisco 12
Santa Clara 12
Bexley 11
Brooklyn 11
Roubaix 11
Turku 11
Brasília 10
Columbus 10
Jinan 10
Phoenix 10
Porto Alegre 10
Quito 10
Rio de Janeiro 10
Warsaw 10
Amsterdam 9
Atlanta 9
Augusta 9
Belo Horizonte 9
Curitiba 9
Dhaka 9
Wroclaw 9
Totale 6.049
Nome #
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 272
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 271
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study. 231
Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population 220
Can Elderly Patients With Newly Diagnosed Glioblastoma be Enrolled in Radiochemotherapy Trials? 218
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 199
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 193
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 191
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 185
Adjuvant radiotherapy in non small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. 179
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection. 167
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 164
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 163
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 162
Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. 162
Temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: a broken promise? 162
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 156
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 156
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 153
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 153
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis 152
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 149
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 148
5-Aminolevulinic Acid and Contrast-Enhanced Ultrasound: The Combination of the Two Techniques to Optimize the Extent of Resection in Glioblastoma Surgery 146
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 145
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 142
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 141
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 138
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study 136
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study 135
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 134
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 132
Radiotherapy vs Follow up in the treatment of pathological stage Ia and Ib non small cell lung cancer. Early stopped analysis of a randomized controlled study. 131
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 131
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 129
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 127
Managing children with brain tumors during the COVID-19 era: Don't stop the care! 124
Regorafenib in Glioblastoma Recurrence: How to Deal With MR Imaging Treatments Changes 124
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 123
Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: a dose-escalation study. 120
The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma 120
Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings? 119
Postoperative infection may influence survival in patients with glioblastoma: simply a myth? 118
Patients’ Satisfaction by SmileInTM Totems in Radiotherapy: A Two-Year Mono-Institutional Experience 118
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 117
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 117
Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. 115
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 114
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 113
Quasi real time in vivo dosimetry for VMAT 113
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 111
Role of radiotherapy in the treatment of fibrosarcoma of the spermatic cord: a case report and review of the literature 110
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 109
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 108
Neuro-Oncology Multidisciplinary Tumor Board: The Point of View of the Neuroradiologist 108
Invasive tumor cells and prognosis in a selected population of patients with glioblastoma multiforme 105
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 104
Treatment of Merkel cell carcinoma with radiotherapy and imiquimod (Aldara): a case report. 102
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 97
Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: Single-institution experience and systematic review 96
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 94
Can automation in radiotherapy reduce costs? 93
A radiotherapy staff experience of gratitude during COVID-19 pandemic 93
Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches 92
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer 92
Which therapeutic approach is feasible for elderly people with glioblastoma? 90
Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy 90
IMproved MAnagement (IM-MA study) in cancer-related pain: the value of a joint approach by an integrated team of radiotherapist and anesthetist 89
Low Tesla magnetic resonance guided radiotherapy for locally advanced cervical cancer: first clinical experience 87
A new frontier of image guidance: Organs at risk avoidance with MRI-guided respiratory-gated intensity modulated radiotherapy: Technical note and report of a case 87
Development of a modelling to correlate site and diameter of brain metastases with hippocampal sparing using volumetric modulated Arc therapy 87
SPHINCTER PRESERVATION IN FOUR CONSECUTIVE PHASE II STUDIES OF PREOPERATIVE CHEMORADIATION: ANALYSIS OF 247 T3 RECTAL CANCER PATIENTS. 87
Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma 85
A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma. 84
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 84
The Safety of Radiotherapy in the Treatment of Primary Cutaneous B-Cell Lymphoma: A Multidisciplinary Systematic Review 84
Dynamic11 c-methionine pet-ct: Prognostic factors for disease progression and survival in patients with suspected glioma recurrence 82
A new standardized data collection system for brain stereotactic external radiotherapy: The PRE.M.I.S.E project 82
Decision Making on Vestibular Schwannoma: Lessons from a Multidisciplinary Board 81
Beyond geometrical overlap: a Dosimetrical Evaluation of automated volumes Adaptation (DEA) in head and neck replanning 80
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 79
MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology 79
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 77
Occurrence and predictors of the fatigue in high-grade glioma patients 77
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication. 77
Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma 75
Locoregional pain treatment. Troubles and prospectives: antalgic radiotherapy 73
Patients’ satisfaction by smileintm totems in radiotherapy: A two-year mono-institutional experience 73
Multimodal treatment of pediatric patients with Askin's tumors: Our experience 71
Intracranial melanocytic meningeal tumours and melanosis oculi: case report and literature review 70
Hypofractionated stereotactic radiotherapy for oligometastatic patients: developing of a response predictive model 69
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 68
Squamous cell carcinoma of the rectum: The treatment paradigm 68
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 67
An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas 67
Hypofractionated stereotactic radiotherapy for oligometastatic patients: developing of a response predictive model 66
Adaptive optimization by 6 DOF robotic couch in prostate volumetric IMRT treatment: Rototranslational shift and dosimetric consequences 65
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 65
Correction to: Multimodal treatment of pediatric patients with Askin's tumors: Our experience (World Journal of Surgical Oncology (2018) 16 (140) DOI: 10.1186/s12957-018-1434-2) 65
Combining magnetic resonance imaging with systemic monocyte evaluation for the implementation of gbm management 65
Totale 11.837
Categoria #
all - tutte 53.816
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021782 0 100 26 76 126 49 70 26 103 47 148 11
2021/20221.106 115 87 26 69 52 37 19 167 49 70 202 213
2022/20232.532 342 347 195 402 194 274 123 191 298 39 79 48
2023/20241.224 57 309 48 112 45 191 60 77 14 47 125 139
2024/20252.309 65 74 182 81 244 76 56 103 363 258 463 344
2025/2026890 845 45 0 0 0 0 0 0 0 0 0 0
Totale 12.962